novocure(NVCR) - 2023 Q4 - Earnings Call Transcript

NovoCure Limited (NASDAQ:NVCR) Q4 2023 Earnings Conference Call February 22, 2024 8:00 AM ET Company Participants Ingrid Goldberg - Investor Relations Bill Doyle - Executive Chairman Asaf Danziger - Chief Executive Officer Ashley Cordova - Chief Financial Officer Frank Leonard - Executive VP and President of NovoCure Oncology Pritesh Shah - Chief Growth Officer Conference Call Participants Jason Bednar - Piper Sandler Jonathan Chang - Leerink Partners Emily Bodnar - H.C. Wainwright Operator Good day and tha ...